Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.37
↑ 93% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthElevated
Average
-5.14
Historical baseline
PeriodValueYoY Change
2025-0.37+90.1%
2024-3.71+27.6%
2023-5.12+41.5%
2022-8.76+44.9%
2021-15.89-310.7%
2020-3.87-136.7%
2019-1.63+31.4%
2018-2.38+14.1%
2017-2.77+59.7%
2016-6.88-